Home_Viewpoints

No Social Media Guidelines from FDA

It seems I’m here again writing a post in response to an FDA announcement. Specifically, in response to the FDA announcing they’re delaying an announcement. And I’m honestly not surprised. As discussed in earlier posts, FDA’s delay of guidance on social media for pharma is, in some ways, understandable. In recent conversations with health digital thought leaders at SXSW, many of us are beginning to wonder if this is even FDA’s remit. Hear me out on this. The FDA is an agency founded to protect the public, and the guidelines around Rx brand communications that have been formed…

Maria Ogneva Discusses Internal Collaboration

Originally posted on Social Media Blog.

I caught up with my good friend Maria Ogneva at Yammer headquarters in San Francisco last week and asked her a few questions about the impact that internal collaboration has on business. Her answer is extremely insightful and she addresses culture, process, technology and of course the social customer.

Maria…

Friday Five: Location-based services update their offerings

Location-based services are continuing to develop and emerge into new, more valuable services. With updates happening every few months and new apps launching weekly, this week’s Friday5 will help marketers and users of location-based services understand recent updates. Also, the goal is to help readers gauge where the industry is heading with some innovative offerings that impact traditionally offline behaviors and continue to create multidimensional experiences.

1. Gowalla enhancements
In December, Gowalla…